Citation Impact
Citing Papers
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
2009 StandoutScience
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast Cells
2009
Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1
1999
Nasopharyngeal carcinoma
2005 Standout
Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma
2002
Idiopathic pulmonary fibrosis
2017 Standout
An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein–Barr Virus Activation
2012
Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
2013
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Necroptosis and its role in inflammation
2015 StandoutNature
Syndemics and the biosocial conception of health
2017 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD
2008
Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications
2000
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Higher Monocyte Expression of TLR2 and TLR4, and Enhanced Pro-inflammatory Synergy of TLR2 with NOD2 Stimulation in Sarcoidosis
2008
T‐cell exhaustion: characteristics, causes and conversion
2010
Activation of host pattern recognition receptors by viruses
2010
LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs
2011
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
IgE and mast cells in allergic disease
2012 Standout
Nasopharyngeal carcinoma
2019 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Sarcoidosis
2013 Standout
Interferon regulatory factors: the next generation
1999
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Identification of Putative Target Genes of the Transcription Factor RUNX2
2013 StandoutNobel
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
2009
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008
2009
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
2005
Two cases of chronic active Epstein–Barr virus infection in which EBV‐specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation
2008
Etiological factors of nasopharyngeal carcinoma
2014
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Links between pediatric and adult asthma
2001
Epstein-Barr virus-associated gastric adenocarcinoma
2019
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Biological aspects of Epstein–Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies
2002
Nasopharyngeal carcinoma
2015 Standout
cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
2011
Hepatosplenic ɑß T-Cell Lymphomas
2001
CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
2016
Expression of Epstein–Barr Virus–Encoded Small RNA (by the EBER-1 Gene) in Liver Specimens from Transplant Recipients with Post-Transplantation Lymphoproliferative Disease
1992
Epstein–Barr virus: 40 years on
2004 Standout
Entry of viruses through the epithelial barrier: pathogenic trickery
2003
Could a herpesvirus be the cause of Kawasaki disease?
2002
Gammaherpesviruses and “Hit-and-Run” Oncogenesis
2000
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Detection of Epstein-Barr Virus in Invasive Breast Cancers
1999
The role of EBERs in oncogenesis
2001
Airway Mucus Function and Dysfunction
2010 Standout
The next generation of bacteriophage therapy
2011
Identification of a new human coronavirus
2004 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Epstein–Barr virus and oncogenesis: from latent genes to tumours
2003
Cross-Talk between Human Dendritic Cell Subsets Influences Expression of RNA Sensors and Inhibits Picornavirus Infection
2010
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma
1990
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Immunohistochemical Studies on Small Intestinal Mucosa in Kawasaki Disease
1993
Exploring the full spectrum of macrophage activation
2008 Standout
Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments
2012
Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells
2011
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
Neuronal Calcium Sensor Synaptotagmin-9 Is Not Involved in the Regulation of Glucose Homeostasis or Insulin Secretion
2010 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
Replication of hepatitis C virus
2007 StandoutNobel
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
2013
Epstein-Barr Virus-Encoded Bcl-2 Homologue Functions as a Survival Factor in Wp-Restricted Burkitt Lymphoma Cell Line P3HR-1
2009
Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.
2000
Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase
2002
Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases
1998
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
γδ T‐cell lymphomas: a homogeneous entity?
2000
Differential Expression Patterns of Runx2 Isoforms in Cranial Suture Morphogenesis
2001
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
2000
Off-targeting and other non-specific effects of RNAi experiments in mammalian cells.
2007
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
2011 StandoutNobel
The Asthma Epidemic
2006 Standout
Viral Infection of the Pregnant Cervix Predisposes to Ascending Bacterial Infection
2013
Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas
2007
Establishment of an oriP Replicon Is Dependent upon an Infrequent, Epigenetic Event
2001
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
1999
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.
1998
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection
2001
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
2006
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Peripheral T‐cell and NK ‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVI th meeting of the European Association for Haematopathology and the Society for Hematopathology
2013
Preterm labor: One syndrome, many causes
2014 StandoutScience
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
TLR9 Is Required for the Gut-Associated Lymphoid Tissue Response following Oral Infection of Toxoplasma gondii
2006
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Inducible Innate Resistance of Lung Epithelium to Infection
2010
Cellular receptors for viruses: links to tropism and pathogenesis
2000
Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.
1994
Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy
2005
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
2011
Epstein-Barr Virus in Gastric Carcinoma
2014
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Coronary Artery Dimensions in Febrile Children Without Kawasaki Disease
2013
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus
2007
Works of Shosuke Imai being referenced
Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
2009
Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006
2003
Dominant expression of interleukin‐10 and transforming growth factor‐β genes in activated T‐cells of chronic active epstein–barr virus infection
2004
Experimental Protection of Mice against Lethal Staphylococcus aureus Infection by Novel Bacteriophage φMR11
2003
Prognostic Factors for Chronic Active Epstein‐Barr Virus Infection
2003
Detection of Epstein–Barr Virus (EBV) in Hepatocellular Carcinoma Tissue: A Novel EBV Latency Characterized by the Absence of EBV-Encoded Small RNA Expression
1999
Epstein‐Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections
1993
Proposed guidelines for diagnosing chronic active Epstein‐Barr virus infection
2005
Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies
1996
PEBP2αA/CBFA1 mutations in Japanese cleidocranial dysplasia patients
2000
CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells
2004
Eradication of epstein–barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1
2005
Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease
1988 Nature
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
2005
Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus
1992
Corticosteroid and Cytokines Synergistically Enhance Toll-Like Receptor 2 Expression in Respiratory Epithelial Cells
2004
Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines
1986
Breast Milk Is Not a Significant Source for Early Epstein‐Barr Virus or Human Herpesvirus 6 Infection in Infants: A Seroepidemiologic Study in 2 Endemic Areas of Human T‐Cell Lymphotropic Virus Type I in Japan
1997
Respiratory Syncytial Virus Infection of Neonatal Monocytes Stimulates Synthesis of Interferon Regulatory Factor 1 and Interleukin-1β (IL-1β)-Converting Enzyme and Secretion of IL-1β
1998
Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells
1998
Induction of Lytic Epstein-Barr Virus (EBV) Infection by Synergistic Action of Rituximab and Dexamethasone Renders EBV-Positive Lymphoma Cells More Susceptible to Ganciclovir Cytotoxicity In Vitro and In Vivo
2005
Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice
2006
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression
1999